Skip to main content
Clinical Trials/NCT01546779
NCT01546779CompletedNot Applicable

The Immediate Effect of Resistive Expiration Via "Volumetric Incentive Spirometer" on Lung Function in Patients With Cystic Fibrosis.

Sheba Medical Center2 sites in 1 country40 target enrollmentStarted: December 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
lung function

Study Overview

Brief Summary

Cystic Fibrosis (CF) patients perform airway clearance incorporating various breathing strategies, to clear secretions from their lungs. Hand held devices may aid mucus expectoration, and also motivate the patient to manage by themselves. Our aims was to study if resistive expiration through "volumetric incentive spirometer" (VISex) can improve lung function in the short term in Cystic Fibrosis (CF) patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
5 Years to 65 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • cystic fibrosis patients

Exclusion Criteria

  • i.v. antibiotic therapy during the experiment day

Outcomes

Primary Outcomes

lung function

Time Frame: fifteen minutes after intervention

Forced expiratory maneuvers were measured before and 15 minutes after intervention.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

The Use of Visual Feedback in Airway... | Clinical Trial